Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
1h
Gilead upgraded to outperform by Leerink on PrEP outlook
Leerink has upgraded Gilead Sciences (GILD) to outperform, citing the growth outlook for its PrEP medication lenacapavir for ...
pharmaphorum
5h
Gilead, MSD say HIV combo could be weekly, oral HIV drug
Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
Star Observer
8h
Douches, Long-Acting Jabs, Implants – All The New HIV Prevention Products Coming Our Way
From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Liberty win first WNBA title
The Vessel to reopen
Helicopter hits radio tower
Oscar makes landfall
WWII code talker dies
American activist Wair dies
Gold hits fresh high
Albany State shooting
Faces new lawsuits
Hezbollah assets targeted
New Mexico flash flooding
Wins third PGA Tour title
Ceasefire talks in Beirut
NYC subway death trial
To roll out AI agents in Nov
Advance to World Series
Blinken's Middle East trip
Opens up on Russian camp
Oakland fire burns homes
Launches OneWeb mission
Baldwin returns to 'SNL'
Urges support for Ukraine
Rock & Roll HOF '24 class
CVS workers strike
Ferry dock collapses in GA
Orionids meteor shower
US probing documents leak
Postpones US tour
Related topics
islatravir
HIV
Gilead Sciences
Feedback